Role of phospholipid transfer protein and preß-high density lipoproteins in maintaining cholesterol efflux from Fu5AH cells to plasma from insulin-resistant subjects

REFERENCES

• Laakso M. Insulin resistance and coronary heart disease. Curr Opin Lipidol 1996; 7: 217–26.
   PubMed Web of Science ®Google Scholar
• Gordon DJ, Rifkind BM. High-density lipopro-tein—the clinical implications of recent studies. N Engl J Med 1989; 321: 1311–6.
   PubMed Web of Science ®Google Scholar
• Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995; 36: 211–28.
   PubMed Web of Science ®Google Scholar
• Lagrost L, Desrumeaux C, Masson D, Deckert V, Gambert P. Strucure and function of the plasma phospholipid transfer protein. Curr Opin Lipidol 1998; 9: 203–9.
   PubMedGoogle Scholar
• Von Eckardstein A, Jauhiainen M, Huang Y, Metso J, Langer C, Pussinen P, et al. Phospholipid transfer protein mediated conversion of high density lipoproteins generates prepi-HDL. Biochim Biophys Acta 1996; 1301: 255–62.
   PubMedGoogle Scholar
• Jiang XC, Francone OL, Bruce C, Milne R, Mar J, Walsh A, et al. Increased prep-high density lipoprotein, apolipoprotein Al, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein Al transgenes. J Clin Invest 1996; 96: 2373–80.
   Google Scholar
• Van Haperen R, Van Tol A, Vermeulen P, Jauhiainen M, Van Gent T, Van den Berg P, et al. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterios-cler Thromb Vasc Biol 2000; 20: 1082–8.
   PubMedGoogle Scholar
• Rothblat GH, De La Llera-Moya M, Atger V, Kellner-Wiebel G, Williams DL, Phillipis MC. Cell cholesterol efflux: integration of old and new insights provides new insights. J Lipid Res 1999; 40: 781–96.
   Google Scholar
• Syvänne M, Castro G, Dengremont C, De Geitere C, Jauhiainen M, Ehnholm C, et al. Cholesterol efflux from Fu5AH cells induced by plasma of subjects with or without coronary heart disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer assay. Atherosclerosis 1996; 127: 245–53.
   Google Scholar
• Riemens SC, Van Tol A, Stulp BK, Dullaart RPF. Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorph-ism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities an their response to hyperinsulinemia in non-diabetic men. J Lipid Res 1999; 40: 1467–74.
   PubMedGoogle Scholar
• Dullaart RPF, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994; 24: 188–94.
   Google Scholar
• Asztalos BF, Roheim PS. Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma. Arterioscler Thromb Vasc Biol 1995; 15: 1419–23.
   PubMed Web of Science ®Google Scholar
• Speijer H, Groener JEM, Van Ramshorst E, Van Tol A. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein in plasma. Atherosclerosis 1991; 90: 159–68.
   Google Scholar
• De La Llera-Moya M, Atger V, Paul JL, Fournier N, Moatti N, Giral P, et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification and transfer. Arterioscler Thromb Vasc Biol 1994; 14: 1056–65.
   PubMedGoogle Scholar
• Ji Y, Jian B, Wang N, Sun Y, De La Llera Moya M, Phillips MC, et al. Scavenger class B I promotes high density lipoprotein-mediated cellu-lar cholesterol efflux. J Biol Chem 1997; 272: 20982— 5.
   Google Scholar
• Young SG, Fielding CJ. The ABC's of cholesterol efflux. Nature Genetics 1999; 22: 316–8.
   PubMed Web of Science ®Google Scholar
• Wolfbauer G, Albers JJ, Oram JF. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim Biophys Acta 1999; 1439: 65–76.
   Google Scholar
• Rye KA, Jauhiainen M, Barter PJ, Ehnholm C. Triglyceride-enrichment of high density lipopro-teins enhances their remodelling by phospholipid transfer protein. J Lipid Res 1998; 39: 613–22.
   PubMed Web of Science ®Google Scholar
• Kunitake ST, Mendel CM, Hennessy LK. Inter-conversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic moblities. J Lipid Res 1992; 33: 1807–16.
   Google Scholar
• Francone OL, Royer L, Haghpassand M. Increased prep-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expres-sing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apo A-I) transgenes. J Lipid Res 1996; 37: 1268–77.
   Google Scholar
• Baldeweg SE, Golay A, Natali A, Balkau B, Del Prato S, Coppack SW, on behalf of the European Group for the study of insulin resistance (EGIR). Insulin resistance, lipid and fatty acid concentra-tions in 867 healthy Europeans. Eur J Clin Invest 2000; 30: 45–52.
   Google Scholar
• Riemens SC, Van Tol A, Sluiter WJ, Dullaart RPF. Plasma phospholipid transfer protein acti-vity is lowered by 24-h insulin and Acipimox administration. Blunted response to insulin in Type 2 diabetic patients. Diabetes 1999; 48: 1631— 7.
   PubMedGoogle Scholar
• Tu AY, Albers H. DNA sequences responsible for reduced promotor activity of human phospholipid transfer protein by fibrate. Biochem Biophys Res Comm 1999; 294: 802–7.
   Google Scholar